نتایج جستجو برای: ژن her2

تعداد نتایج: 30284  

2014
Mari Hosonaga Yoshimi Arima Eiji Sugihara Norio Kohno Hideyuki Saya

Human epidermal growth factor receptor 2 (HER2)-positive breast cancer is treated with HER2-targeted agents, such as trastuzumab and lapatinib, that suppress signaling by phosphatidylinositol 3-kinase (PI3K)-Akt and MAPK pathways. However, resistance to HER2-targeted therapy remains a major clinical problem. Overexpression of CD24 has been detected in many cancers and is associated with a poor ...

Ardeshir Ghavamzadeh, Fatemeh Nevisi, Gholamreza Javadi, Hossein Pashaiefar, Kamran Alimoghaddam, Marjan Yaghmaie, Masoud Iravani,

Background: Gastric cancer (GC) is considered as one of the most common types of cancer worldwide with poor prognosis and generally limited treatment options. Recent studies have indicated that HER2, MDM2, MYC, MET, and TP53 play an important role in the development of gastric cancer. Therefore, the aim of this study was to evaluate the incidence of amplification/deletion of these genes in pati...

سید علی‌حسین صابری سید محمود لطیفی, سید محمّد حسینی محسن شفیعی

زمینه و هدف:سرطان سینه شایع­ترین سرطان در بین زنان می­باشد. یکی از روش­های درمان این بیماری رادیوتراپی می­باشد. مکانیسم­های مختلف شامل تنظیم سیکل سلولی، ترمیم DNA  و آپوپتوزیس در پاسخ به تابش پرتویی در سلول­ها فعال می­شوند. با بررسی وضعیت مکانیسم­ها و مارکرهای بیولوژیکی، می­توان پاسخ سلول­های فرد به پرتو تابشی(حساسیت پرتویی) را ارزیابی کرد و با توجه به حساسیت پرتویی فرد، برنامه درمانی متناسب با...

Journal: :Human pathology 2017
Yoshifumi Shimada Ryoma Yagi Hitoshi Kameyama Masayuki Nagahashi Hiroshi Ichikawa Yosuke Tajima Takuma Okamura Mae Nakano Masato Nakano Yo Sato Takeaki Matsuzawa Jun Sakata Takashi Kobayashi Hitoshi Nogami Satoshi Maruyama Yasumasa Takii Takashi Kawasaki Kei-Ichi Homma Hiroshi Izutsu Keisuke Kodama Jennifer E Ring Alexei Protopopov Stephen Lyle Shujiro Okuda Kohei Akazawa Toshifumi Wakai

HER2-targeted therapy is considered effective for KRAS codon 12/13 wild-type, HER2-positive metastatic colorectal cancer (CRC). In general, HER2 status is determined by the use of immunohistochemistry (IHC) and fluorescence in situ hybridization (FISH). Comprehensive genomic sequencing (CGS) enables the detection of gene mutations and copy number alterations including KRAS mutation and HER2 amp...

Objective(s): Expression of HER2 in gastric carcinoma has direct prognostic and therapeutic implications in patient management. The aim of this study is to determine whether a relationship exists between standardized uptake value (SUV) and expression of HER2 in advanced gastric carcinoma. Methods: We analyzed the 18F-FDG PET/CT results of 109 patients that underwent gastrectomy for advanced gas...

Objective(s): Development of molecules that specifically recognize cancer cells is one of the major areas in cancer research. Human epidermal growth factor receptor 2 (HER2) is specifically expressed on the surface of breast cancer cells. HER2 is associated with an aggressive phenotype and poor prognosis. In this study we aimed to isolate RNA aptamers that specifically bind to HER2 overexpressi...

2017
Tonghui Wang Ye Xu Shuyan Sheng Hua Yuan Tao Ouyang Jinfeng Li Tianfeng Wang Zhaoqing Fan Tie Fan Benyao Lin Yuntao Xie

It is well documented that human epidermal growth factor receptor 2 (HER2) overexpression/amplification is associated with poor survival in breast cancer patients. However, it is largely unknown whether HER2 somatic mutations are associated with survival in HER2-negative breast cancer patients. Here, we identified HER2 somatic mutations in tumors from 1348 unselected breast cancer patients by s...

2018
Yun Gyoung Kim Yi Na Yoon Hyang Suk Choi Ji-Hyun Kim Hyesil Seol Jin Kyung Lee Min-Ki Seong In Chul Park Kwang Il Kim Hyun-Ah Kim Jae-Sung Kim Woo Chul Noh

Although it has been proposed that the beneficial effect of HER2-targeted therapy in HER2-negative breast cancer is associated with the molecular subtype conversion, the underlying mechanism and the clinical biomarkers are unclear. Our study showed that breast cancer stem cells (BCSCs) mediated HER2 subtype conversion and radioresistance in HER2-negative breast cancer cells and evaluated serum ...

2013
Sabina Berezowska Alexander Novotny Karina Bauer Annette Feuchtinger Julia Slotta-Huspenina Karen Becker Rupert Langer Axel Walch

BACKGROUND Her2 expression and amplification occurs in a significant subset of gastro-esophageal carcinomas. Her2 is a client protein of molecular chaperones, e.g. heat shock protein (HSP) 90, rendering targeted therapies against Her2/HSP90 an interesting approach. This study aimed to investigate the role and relationship of Her2 and HSP90 in gastric and gastro-esophageal adenocarcinomas. MAT...

Journal: :International journal of clinical and experimental pathology 2014
Xin Hua Long Kai Zhao Guo Mei Zhang Yang Zhou Rong Ping Zhou Zhi Li Liu Zhi Hong Zhang

Elevated expression of fatty acid synthase (FASN) and human epidermal growth factor receptor-2 (HER2) are observed in human osteosarcoma (OS). The aim in this study is to investigate a possible connection between FASN expression and the activity of HER2. The immunohistochemistry staining was conducted on 24 OS specimens from patients, which revealed a significant positive correlation between FA...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید